-
admin
Posts
Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days
WARREN, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN) is a clinical-stage specialty immunotherapy biotech developing...
Green, Low-Carbon, and Full-fledged Smart Mobility Products Gain Attention at the 136th Canton Fair
GUANGZHOU, China, Oct. 19, 2024 /PRNewswire/ — The 136th Canton Fair, which has opened in Guangzhou, has fully upgraded the New Energy Resources Exhibition Section...
HUAWEI AppGallery Returns to Thailand Game Show 2024 with Exciting Lineup of Activities and Rewards to Game Lovers
BANGKOK, Oct. 19, 2024 /PRNewswire/ — The largest gaming exhibition in Southeast Asia is happening now! HUAWEI AppGallery is thrilled to announce its return to...
Intellectual property empowers the development of new quality productivity in Tai’an, China
TAI’AN, China, Oct. 19, 2024 /PRNewswire/ — This is a report from the Shandong Office of Hong Kong Business Daily. Intellectual property is a core element...
Dynamic moves help China navigate economic landscape
BEIJING, Oct. 19, 2024 /PRNewswire/ — A report from China Daily The opening ceremony of the Annual Conference of Financial Street Forum 2024 is held...
Beautiful Ocean Coin: Revolutionizing Marine Conservation Through Blockchain Technology
Beautiful Ocean Coin (BOC) launches a blockchain platform to enhance transparency and funding for marine conservation, drawing immediate interest. Bethany, Oklahoma, Oct. 18, 2024 (GLOBE...
Adhesive Tapes Market to Reach USD 134.6 Billion by 2032 Driven by Growing Applications in Healthcare and Packaging Industries | Research by SNS Insider
The rise in demand for adhesive tape-based beauty and healthcare products continues to accelerate due to advancements in scientific research and increasing consumer awareness about...
Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal
FLORHAM PARK, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative medicine company developing and commercializing placental-derived technologies, today announced that...
Three-year Results for EYLEA HD® (aflibercept) Injection 8 mg Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended Dosing Intervals in Patients with Diabetic Macular Edema
88% of EYLEA HD patients had a last assigned dosing interval of ≥12 weeks at week 156, while sustaining visual and anatomic improvements achieved in...
Roche’s Vabysmo improved vision in underrepresented populations with diabetic macular edema (DME) in a first-of-its-kind study
The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with diabetic macular edema (DME) treated with Vabysmo who...
